AIS's Health Business Daily is a daily email newsletter with strategic business stories written by experienced AIS Health reporters, as well as other information of interest to health care business leaders — including news from the nation’s leading health insurers, developments from the federal and state governments that impact the health care industry, and exclusive datapoints from Subscribe now to get an issue delivered to your inbox every morning!
November 6, 2017
Today's Featured Story
Some Texas State Workers Can’t Get Providers in Blues’ HMO Network
Reprinted from HEALTH PLAN WEEK
Texas state officials concede that network adequacy problems arose when they switched to a new health plan for state employees on Sept. 1. In Wichita Falls, major providers sped through negotiations with Blue Cross and Blue Shield of Texas — selected in competitive bidding as the new third party administrator (TPA) for the Employees Retirement System (ERS) of Texas’s self-funded plans. That helped to avert major disruption to plan members there. But it wasn’t as smooth elsewhere....  Read Full Story
Subscribe to AIS's Health Plan Week

Today's AIS Health Datapoint
32% ... of covered lives in the United States have access to Pulmozyme, a cystic fibrosis drug, on the preferred tier. Pulmozyme is the most likely cystic fibrosis drug to have preferred status.
SOURCE: MMIT Analytics, as of Oct. 27, 2017

The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Questions or suggestions about the content in AIS's HEALTH BUSINESS DAILY should be directed to Executive Editor Jill Brown at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2017 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to